We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Health and Fitness

Personalised Co

Status: Extended

Oct 19th 2020 - Dec 12th 2020

Personalised Co. is a nutrition company on a mission to help as many people as possible reach their health and wellbeing goals by making supplements accessible and affordable. The company asserts that it provides personalised nutritional products to its consumers. Customers are required to take a quiz on the company's portal, based on which, the company's custom-built algorithm creates nutritionist-approved solutions tailored to the specific needs and goals of each customer. Personalised Co. has delivered 270,000 daily vitamin sachets till date. The company has also raised £192,000 from private investors and its first crowdfunding campaign in 2019. It achieved its milestone month in April 2020 earning £48,000 in revenue and delivering over 1,700 personalised vitamins and protein orders. The company will use the investment to level-up its operations, expand its product line and develop its companion-application.

read more read less

Personalised Co Rating Review

Pitch rating powered by CROWDRATING

Rated on 22/10/2020

Pitch Rated

54%

Insufficient Data

Management

87%

Product

76%

Investment

UNRATED*

* Section unrated owing to insufficient or incomplete information available at the time of rating.

Log in to view amount pledged

    Log in to view target

    £3,526,435
    pre-money valuation

    6.62%
    equity available

    233
    investors

    £1,723
    pledge per investor

    11710632
    company number

    Active
    company status

    04/12/2018
    incorporated 5 years

    Previous Funding rounds
    19 Apr 24 Seedrs £401,417 / 161% 54.33%
    News

What the ratings mean

  • 49% and under
    We suggest potential investors carry out further study of their own
    50-64%
    Room for improvement
    65-79%
    Worth considering
    80%+
    Gold rating, our highest rating

RISK WARNING - The ratings are based on the information provided in the fund raiser’s pitch deck, business plans and financial forecasts which have appeared on a FCA regulated crowdfunding site. Where possible we validate the business plan to public sources such as LinkedIn, Companies House, Credit Agencies and internet searches. We cannot guarantee the information is correct. The ratings report takes no account of the investors/ individual circumstances. Do your own due diligence and get professional advice before investing. Your capital is at risk when investing in private companies.

Login to view the full report

Management 87%

Skills 82%
Personalised Co is managed by a diverse and qualified team that includes three Co-founders - Head of Logistics, Head of Marketing, and a Strategic Advisor. The Founder/Head of Logistics is proficient in Event Management, Customer Service, Social Media Marketing, and Investment Properties. The Co-founder/Head of Marketing is skilled in Management, Entrepreneurship, Business Strategy, Business Development, and Start-ups. The Co-founder/Strategic Advisor is skilled in Nutrition, Sports, Corporate Governance, Strategic planning, and Digital Marketing. The CTO/Head of Engineering is proficient in Problem Solving, Python, Software Development, Web Development, Analytical Skills, Web Applications, Data Analysis, E-commerce and Risk Management.

0 comments

Log in to comment


Funding progress

Log in to view funding progress.


More from Health and Fitness

Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld

Log in to view amount pledged

    Log in to view target

    £3,526,435
    pre-money valuation

    6.62%
    equity available

    233
    investors

    £1,723
    pledge per investor

    11710632
    company number

    Active
    company status

    04/12/2018
    incorporated 5 years

    Previous Funding rounds
    19 Apr 24 Seedrs £401,417 / 161% 54.33%
    News
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph